Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Pansclerotic morphea: A male child with hemiatrophy of lower limb.

Dasgupta MK, Patra C, Sarkar S, Das S.

Indian Dermatol Online J. 2014 Apr;5(2):170-2. doi: 10.4103/2229-5178.131092.

2.

Unilateral linear pansclerotic morphea affecting face and limbs.

Padmavathy L, Rao LL.

Indian J Dermatol Venereol Leprol. 2005 May-Jun;71(3):192-4.

3.

Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.

Kim A, Marinkovich N, Vasquez R, Jacobe HT.

J Rheumatol. 2014 Jan;41(1):106-12. doi: 10.3899/jrheum.130029. Epub 2013 Dec 1.

4.

[Pansclerotic morphea with a rapidly fatal outcome in an 11-year-old girl].

Hardy J, Audouin-Pajot C, Abid A, Chiotasso D, Coustets B, Suc A, Timsit P, Mouthon L, Mazereeuw-Hautier J.

Ann Dermatol Venereol. 2016 Dec;143(12):836-840. doi: 10.1016/j.annder.2016.06.010. Epub 2016 Aug 2. French.

PMID:
27496274
5.

Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution.

Melani L, Cardinali C, Giomi B, Schincaglia E, Caproni M, Fabbri P.

Skinmed. 2005 May-Jun;4(3):188-90.

PMID:
15891259
6.

Disabling pansclerotic morphea of childhood--unusual case and management challenges.

Forsea AM, Cretu AN, Ionescu R, Giurcaneanu C.

J Med Life. 2008 Jul-Sep;1(3):348-54.

7.

Disabling pansclerotic morphea of childhood with extracutaneous manifestations.

Kura MM, Jindal SR.

Indian J Dermatol. 2013 Mar;58(2):159. doi: 10.4103/0019-5154.108079.

8.

[Incapacitating pansclerotic morphea in childhood].

Ferrandiz C, Henkes J, González J, Peyri J.

Med Cutan Ibero Lat Am. 1981;9(5):377-82. Spanish.

PMID:
7038353
9.

Disabling pansclerotic morphea of children.

Diaz-Perez JL, Connolly SM, Winkelmann RK.

Arch Dermatol. 1980 Feb;116(2):169-73.

PMID:
7356347
10.

Adult-onset unilateral disabling pansclerotic morphea.

Singh A, Singhal K, Choudhary S, Bisati S, Arora M.

Indian J Dermatol. 2014 May;59(3):316. doi: 10.4103/0019-5154.131459.

11.

Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.

Roldan R, Morote G, Castro Mdel C, Miranda MD, Moreno JC, Collantes E.

J Rheumatol. 2006 Dec;33(12):2538-40. Erratum in: J Rheumatol. 2007 Aug;34(8):1786. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

PMID:
17143989
12.

Pansclerotic morphea treated with UVA: a case report.

Yildirim M, Baysal V, Aridogan BC, Kesici D, Erturan I.

J Dermatol. 2003 Aug;30(8):625-7.

PMID:
12928533
13.

Update on the classification and treatment of localized scleroderma.

Bielsa Marsol I.

Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13. Review.

PMID:
23948159
14.

Disabling pansclerotic morphea: clinical presentation in two adults.

Maragh SH, Davis MD, Bruce AJ, Nelson AM.

J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S115-9.

PMID:
16021158
15.

[Plaque-type scleroderma associated with linear and oesophageal features and facial and extra-facial hemiatrophy].

Mégarbané H, Tomb R, Makhoul E.

Ann Dermatol Venereol. 2007 Jan;134(1):68-71. French.

PMID:
17384549
16.

[Morphea or juvenile localised scleroderma: Case report].

Strickler A, Gallo S, Jaramillo P, de Toro G.

Rev Chil Pediatr. 2016 Jul-Aug;87(4):279-83. doi: 10.1016/j.rchipe.2016.01.013. Epub 2016 Mar 12. Spanish.

17.

Squamous cell carcinoma and eosinophilia in a long-term course of pansclerotic morphea.

Grewal I, Khan O, Davis W.

BMJ Case Rep. 2014 Oct 13;2014. pii: bcr2014205737. doi: 10.1136/bcr-2014-205737.

18.

Morphea in Childhood: An Update.

Aranegui B, Jiménez-Reyes J.

Actas Dermosifiliogr. 2018 May;109(4):312-322. doi: 10.1016/j.ad.2017.06.021. Epub 2017 Dec 14. English, Spanish.

PMID:
29248149
19.

Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.

Wollina U, Buslau M, Heinig B, Petrov I, Unger E, Kyriopoulou E, Koch A, Köstler E, Schönlebe J, Haroske G, Doede T, Pramatarov K.

Int J Low Extrem Wounds. 2007 Dec;6(4):291-8. Review.

PMID:
18048875
20.

Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association.

Devidayal, Singh S, Kumar L, Radotra BD.

Rheumatol Int. 2002 Jan;21(4):158-60.

PMID:
11843172

Supplemental Content

Support Center